Skip to main page content

Scientific Advisory Group

Scientific Advisory Group Membership List

NameOrganisation
Dr Máirín Ryan Director of HTA, HIQA
Dr Patricia Harrington HTA Project Manager, HIQA
Dr Caroline Waldron HTA Project Manager, HIQA
Dr Michael Barry National Centre for Pharmacoeconomics
Dr Lesley Tilson National Centre for Pharmacoeconomics
Mr Shaun Flanagan HSE Corporate Pharmaceutical Unit
Dr Davida de la Harpe HSE Health Intelligence
Dr Valerie Walshe HSE Economist
Ms Kathy Cargill IMSTA – Irish Medical & Surgical Trade Association
Dr Loretto Lacey Lacey Solutions Ltd
Prof Mike Drummond Prof. of Health Economics, University of York
Prof Mark Sculpher Prof. of Health Economics, University of York
Dr Gráinne Flannelly Consultant in Obstetrics & Gynaecology
Mr Brian Murphy Irish Pharmaceutical Healthcare Association
Dr Linda Sharp Epidemiologist, National Cancer Registry
Dr Alan Smith National Cancer Screening Service
Dr Andrew Murphy Professor of General Practice, Clinical Sciences Institute, NUI, Galway
Dr Tony Holohan Department of Health & Children, Chief Medical Officers Office Representative
Mr John Dowling Irish Cancer Society Representative
Professor Ciaran O'Neill Professor of Health Technology Assessment, Department of Economics, NUI Galway
Mr Stephen McMahon Irish Patients Association Representative


Terms of reference

Members of the Scientific Advisory Group will:

  • Contribute fully to the work, debate and decision-making processes of the Group by providing expert technical and scientific guidance at SAG meetings as appropriate.
  • Be prepared to occasionally provide expert advice on relevant issues outside of SAG meetings, as requested
  • Support the Authority in the generation of Guidelines to establish quality standards for the conduct of HTA in Ireland
  • Support the Authority in the development of methodologies for effective HTA in Ireland
  • Advise the Authority on its proposed HTA Guidelines Work Plan and on priorities as required
  • Review the project plan outline and advise on priorities, as required.
  • Review the draft report from the Evaluation Team and recommend amendments as appropriate.
  • Contribute to the Authority’s development of its approach to HTA by participating in an evaluation of the process on the conclusion of the assessment.